Skip to main content
SpringerLink
Log in

Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

In normal subjects recombinant human growth hormone (rhGH) increases glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) through the action of insulin-like growth factor-I (IGF-I). We have measured clearance of inulin and para-aminohippuric acid in 18 children with chronic renal failure (CRF) during their 1st year of rhGH treatment to look at the immediate (first 3 h), short-term (1 week) and long-term (1 year) effects of treatment. On day 1 mean (range) age was 9.1 (4.9–13.9) years, GFR 19 (9–58) and ERPF 77 (34–271) ml/min per 1.73 m2. During treatment height velocity increased from 4.5 (1.7–6.5) to 9.5 (4.8–12.7) cm/year (P<0.0001). Two children required dialysis after 0.75 years and 1 child was electively transplanted after 0.5 years. There were no other serious adverse events. GFR and ERPF were unchanged in the 3 h following rhGH. GFR remained constant on day 8, 22 (6–56) and after 1 year, 20 (9–59) ml/min per 1.73 m2. ERPF increased to 96 (33–276) ml/min per 1.73 m2 on day 8P=0.005), and remained elevated, but not significantly so, at 99 (24–428) ml/min per 1.73 m2 at 1 year. Fasting IGF-I increased from 147 (46–315) ng/ml to 291 (61–673) by day 8P<0.003), and to 341 (101–786) ng/ml at 1 year. There was no correlation between the change in IGF-I and renal function. Blood pressure, albumin excretion and dietary protein intake were unchanged by treatment. The significance of increased ERPF after 1 week of rhGH in CRF is unclear, but long-term follow-up of renal function is indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rees L, Rigden SPA, Ward G, Preece M (1990) Treatment of short stature in renal disease with recombinant human growth hormone. Arch Dis Child 65: 856–860

    Google Scholar 

  2. Lippe B, Fine RN, Koch VH, Sherman BM (1988) Accelerated growth following treatment of children with chronic renal failure with recombinant human growth hormone (Somatrem): a preliminary report. Acta Paediatr Scand [Suppl] 343: 127–131

    Google Scholar 

  3. Johansson G, Sietniks A, Janssens F, Proesmans W, Vanderschueren-Lodeweyckx M, Holmberg C, Sipila I, Broyer M, Rappaport R, Albertsson-Wikland K, Berg U, Jodal U, Rees L, Rigden SPA, Preece MA (1990) Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies. Acta Paediarr Scand [Suppl] 370: 36–42

    Google Scholar 

  4. Corvilian J, Abramow M, Bergans A (1962) Some effects of human growth hormone on renal haemodynamics and on tubular phosphate transport in man. J Clin Invest 41: 1230–1235

    Google Scholar 

  5. Parving HH, Noer I, Mogensen CE, Svendsen PA (1978) Kidney function in normal man during short-term growth hormone infusion. Acta Endocrinol (Copenh) 89: 796–800

    Google Scholar 

  6. Christiansen JS, Gammelgaard J, Ørskov H, Andersen AR, Telmer S, Parving HH (1981) Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11: 487–490

    Google Scholar 

  7. Hirschberg R, Rabb H, Begamo R, Kopple JD (1989) The delayed effect of growth hormone on renal function in humans. Kidney Int 35: 865–870

    Google Scholar 

  8. Guler HP, Schmid C, Zapf J, Froesch ER (1989) Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86: 2868–2872

    Google Scholar 

  9. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER (1989) Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 121: 101–106

    Google Scholar 

  10. Haffner D, Zacharewicz S, Mehls O, Heinrich U, Ritz E (1989) The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 32: 266–269

    Google Scholar 

  11. Tönshoff B, Heinrich U, Mehls O (1991) How safe is the treatment of uraemic children with recombinant human growth hormone? Pediatr Nephrol 5: 454–460

    Google Scholar 

  12. Tönshoff B, Tönshoff C, Mehls O, Pinkowski J, Blum WF, Heirich U, Stover B, Gretz N (1992) Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate. Eur J Pediatr 151: 601–607

    Google Scholar 

  13. Fine RN, Kohaut EC, Brown D, Perman AJ (1994) Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicentre randomised doubleblind placebo-controlled study. J Pediatr 124: 374–382

    Google Scholar 

  14. O'Shea MH, Miller SB, Hammerman MR (1993) Effects of IGFI on renal function in patients with chronic renal failure. Am J Physiol 264: F917-F922

    Google Scholar 

  15. Brenner BM (1985) Nephron adaptation to renal injury or ablation. Am J Physiol 249: F324-F337

    Google Scholar 

  16. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. II. Arch Dis Child 41: 613–636

    Google Scholar 

  17. Roe JH, Epstein JH, Goldstein NP (1949) A photometric method for the determination of inulin in plasma and urine. J Biol Chem 178: 839–845

    Google Scholar 

  18. Smith HW, Finkelstein L, Aliminosa L (1954) The renal clearance of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24: 388–404

    Google Scholar 

  19. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL (1986) Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uraemic serum. J Clin Endocrinol Metab 63: 1186–1192

    Google Scholar 

  20. Rizzoni G, Basso T, Setari M (1984) Growth in chidren with chronic renal failure on conservative treatment. Kidney Int 26: 52–58

    Google Scholar 

  21. Samaan N, Freeman R (1970) Growth hormone levels in severe renal failure. Metabolism 19: 102–113

    Google Scholar 

  22. Ikkos D, Ljunggren H, Luft R (1956) Glomerular filtration rate and plasma flow in acromegaly. Acta Endocrinol (Copenh) 21: 226–236

    Google Scholar 

  23. Christiansen JS, Gammelgaard J, Frandsen M, Parving HH (1981) Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetes. Diabetologia 20: 451–456

    Google Scholar 

  24. Gerschberg H, Heinemann HO, Stumpf HH (1957) Renal function studies and autopsy report in a patient with gigantism and acromegaly. J Clin Endocrinol Metab 17: 377–385

    Google Scholar 

  25. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE (1988) Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-I. Am J Pathol 131: 398–403

    Google Scholar 

  26. Kawaguchi H, Katsumi I, Mori H, Hayashi Y, Makino S (1991) Renal pathology in rats bearing tumour-secreting growth hormone. Pediatr Nephrol 5: 533–538

    Google Scholar 

  27. Rose GA (1969) Measurement of glomerular filtration rate by inulin clearance without urine collection. BMJ 2: 91–93

    Google Scholar 

  28. Maxwell H, Nair DR, Rees L (1994) Comparision of glomerular filtration rate as measured by constant infusion of inulin with and without urine collections (abstract). Pediatr Nephrol 8: C58

    Google Scholar 

  29. D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81: 935–939

    Google Scholar 

  30. Hirschberg R, Kopple JD, Blantz RC Tucker BJ (1991) Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87: 1200–1206

    Google Scholar 

  31. Miller SB, Hansen VA, Hammerman MR (1990) Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am J Physiol 259: F747-F751

    Google Scholar 

  32. Allen DB, Fogo A, El-Hayek R, Langhough R, Friedman AL (1992) Effects of prolonged growth hormone administration in rats with chronic renal insufficiency. Pediatr Res 31: 406–410

    Google Scholar 

  33. Fagin JA, Melmed S (1987) Relative increase in insulin-like growth factor I messenger ribonucleic acid levels in compensatory renal hypertrophy. Endocrinology 120: 718–724

    Google Scholar 

  34. Lajara R, Rotwein P, Bortz JD, Hasen VA, Sadow JL, Betts CR, Rogers SA, Hammerman MR (1989) Dual regulation of insulin-like growth factor I expression during renal hypertrophy. Am J Physiol 257: F252-F261

    Google Scholar 

  35. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD (1989) Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124: 40–48

    Google Scholar 

  36. Yang CW, Striker LJ, Pesce C, Chen WY, Peten EP, Elliot S, Doi T, Kopchick, Striker GE (1993) Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Lab Invest 68: 62–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paediatric Nephrology, Royal Free Hospital, Pond Street,Hampstead, NW3 2QG, London, UK

    Heather Maxwell & Lesley Rees

  2. Renal Research Unit, Royal Free Hospital, Pond Street, Hampstead, NW3 2QG, London, UK

    Devati R. Nair

  3. Children's Renal Unit, Evelina Children's Hospital, Guy's Hospital, SE1 9RT, London, UK

    R. Neil Dalton & Susan P. A. Rigden

Authors
  1. Heather Maxwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Devati R. Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Neil Dalton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan P. A. Rigden
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lesley Rees
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maxwell, H., Nair, D.R., Dalton, R.N. et al. Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure. Pediatr Nephrol 9, 458–463 (1995). https://doi.org/10.1007/BF00866727

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00866727

Key words

Search

Navigation